The Diamond Education Foundation captures the current revolution in migraine therapeutics driven by an unprecedented understanding of CGRP biology and novel treatments.
Key Topics
- CGRP biology and migraine pathophysiology
- Monoclonal antibodies — efficacy and patient selection
- Gepants for acute and preventive treatment
- Ditans — new acute migraine therapy
- Neuromodulation devices in migraine
Target Audience
Neurologists, headache specialists, and primary care physicians managing migraine patients.
